Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Processa Pharmaceuticals, Inc.

NASDAQ: PCSA · Life Sciences · 5 alerts · CIK 1533743

Share price
$1.72Close, Nov 16
Market cap
$4.81M
Shares outstanding
2.8MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Processa Pharmaceuticals, Inc. filings on SEC EDGAR ↗

8:47 AM ET 8-K
Regulatory Approval

Processa Pharmaceuticals Regulatory Approval

Processa Pharmaceuticals announced that the FDA has cleared its Investigational New Drug (IND) application for VT-7208, allowing the company to initiate a Phase 2 study in patients with chronic spontaneous urticaria. The company also appointed Dr. Sheila Gujrathi as Executive Chair and entered into a research collaboration with Generian Pharmaceuticals to expand its pipeline.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.